A detailed history of Verition Fund Management LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 7,449 shares of ACLX stock, worth $509,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,449
Holding current value
$509,213
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$75.39 - $106.53 $561,580 - $793,541
7,449 New
7,449 $567,000
Q1 2023

May 15, 2023

BUY
$26.92 - $33.94 $332,327 - $418,989
12,345 New
12,345 $380,000

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.